Insider purchases made by high-level executives is at its handiest when the primary stock in question has seen transactions within the past 180 days. Over the last 180-day time frame, Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) has experienced 1 unique insiders purchasing, and zero insider sales ( see the details of insider trades here ).